Welcome to QPMED Global Ltd

Business Scope & Objectives

QPMED Global Ltd is based in Edinburgh, Scotland and operates on an international basis with business clients in countries including the United Kingdom, the Republic of Ireland, Germany, the USA, India, Australia and Japan.

The company seeks to provide an external resource to businesses within the pharmaceutical and associated healthcare industries with the objective of assisting firms in improving and maintaining regulatory compliance.

Personnel & Partnership

QPMED Global Ltd is owned and managed by Vijay and Janet Khindria.

Vijay Khindria has had over 35 years experience within the pharmaceutical industry. Further to graduating in Chemistry from Heriot Watt University, Edinburgh, Vijay began his career as an analytical chemist and subsequently took up management posts in Quality Control and Quality Assurance with a number of pharmaceutical companies including blue chip pharma. Vijay is registered as a Qualified Person (QP) under the terms of European Directive 2001/83/EEC and is currently on the Marketing & Import Authorisations (MIA's) for companies located in the United Kingdom and the Republic of Ireland. An experienced GMP auditor, Vijay has audited both Formulation and API facilities across Europe and the Asia Pacific region. Vijay has been operating as a pharmaceutical consultant since 2005 and in that time has assisted small to medium sized pharmaceutical companies in improving their GMP compliance and achieving successful regulatory inspections by the Competent Authorities such as the UK's MHRA and the Irish Medicines Board.

Vijay Khindria is also a Senior Associate with another pharmaceutical consulting group, I K Sykes Associates (IKSA) based in Rotterdam, the Netherlands. As a consequence of this association there is access to assistance from colleagues with vast experience in regulatory compliance in the pharmaceutical industry. This ensures that appropriate and sufficient resource is available to address client needs commensurate with project size and complexity.
MHRA Compliance Monitor

From May 2023 Vijay has been deemed eligible by the MHRA to act as a Compliance Monitor (CM) in MHRA’s pilot compliance monitor programme for GMP remediation supervision activities.